Home
Browse
Prime browse
Clustered VIS browse
Search
Curation
Gene
Target gene
All
Oncogene
Tumor suppressor gene
Nearby gene
All
Oncogene
Tumor suppressor gene
MicroRNA
RNA-interaction
ncRNA
Host2Host
Host2Virus
Virus2Host
• miRNA
Host2Host
Host2Virus
Virus2Host
• lncRNA
Host2Host
Host2Virus
Virus2Host
Download
Statistics
Help
VISDB
Viral Integration Site DataBase
Homepage
Prime VIS Browse Options
TVIS42000289
Basic Information
VIS ID
TVIS42000289
Fusion event
EBV-FSCN1 integration
Validated
No
Detection method
WGS
Data source
Curated
Sample type
Cell line
Disease
Nasopharyngeal carcinoma (NPC)
Quality evaluation
Normal
Reported year
2005
PubMed ID
15681063
Virus Sequence
Virus name
EBV
Reference genome
NC007605
Start
11063
Orient
+
Integrated sequence
AAAAAATTTATGGTTCAGTGCGTCGAGTGCTATCTTTGGAACAGTAGAAAATTGAACCTTGTTGGCGGGAGAAGGAATAACGCCTTATCTGGGAGGAGCG| |ACGGATTATAGCCAATAAGAGAGCTCAAGACGCAGGGCTCGCAAAGTATAGTGGCCCCGTGGGACCTTAGAGGTGGAGCAACGTCTAAAGTGGTAATAAC
Host Sequence
Chromosome
chr7
Cytoband
p22.1
Reference genome
GRCh37/hg19
Start
5646403/5606772 (Hg38)
End
5646403/5606772 (Hg38)
Orient
+
Location type
Intronic
Fragile sites / regions
FRA7B
Target gene
FSCN1
miRNAs that regulate target gene
hsa-mir-133a-3p
;
hsa-mir-145-5p
;
hsa-mir-143-3p
;
hsa-mir-133b
;
hsa-mir-30a-5p
;
hsa-mir-221-3p
;
hsa-mir-17-3p
;
hsa-mir-6801-5p
;
hsa-mir-7162-3p
;
hsa-mir-4649-3p
;
hsa-mir-6501-3p
;
hsa-mir-583
;
hsa-mir-24-3p
;
hsa-mir-6792-5p
;
hsa-mir-4283
;
hsa-mir-760
;
hsa-mir-5008-5p
;
hsa-mir-3663-3p
;
hsa-mir-1247-3p
;
hsa-mir-7113-5p
;
hsa-mir-761
;
hsa-mir-3619-5p
;
hsa-mir-214-3p
;
hsa-mir-4705
;
hsa-mir-6813-5p
;
hsa-mir-6085
;
hsa-mir-29c-3p
;
hsa-mir-29b-3p
;
hsa-mir-29a-3p
;
hsa-mir-6816-5p
;
hsa-mir-3196
;
hsa-mir-3180-3p
;
hsa-mir-3180
;
hsa-mir-6787-5p
;
hsa-mir-6721-5p
;
hsa-mir-663a
;
hsa-mir-1908-5p
;
hsa-mir-4763-3p
;
hsa-mir-1207-5p
;
hsa-mir-4749-5p
;
hsa-mir-4706
;
hsa-mir-6722-3p
;
hsa-mir-1909-3p
;
hsa-mir-6802-3p
;
hsa-mir-4284
;
hsa-mir-6862-3p
;
hsa-mir-6784-3p
;
hsa-mir-4707-5p
;
hsa-mir-6764-5p
;
hsa-mir-1915-3p
;
hsa-mir-6837-5p
;
hsa-mir-4685-5p
;
hsa-mir-5088-5p
;
hsa-mir-133a-5p
;
hsa-mir-326
;
hsa-mir-429
;
hsa-mir-200b-3p
;
hsa-mir-184
;
hsa-mir-185-3p
;
hsa-mir-2115-5p
;
hsa-mir-299-3p
;
hsa-mir-3180-5p
;
hsa-mir-3652
;
hsa-mir-3919
;
hsa-mir-4265
;
hsa-mir-4296
;
hsa-mir-4322
;
hsa-mir-4417
;
hsa-mir-4430
;
hsa-mir-4446-3p
;
hsa-mir-4489
;
hsa-mir-4492
;
hsa-mir-4498
;
hsa-mir-4505
;
hsa-mir-4533
;
hsa-mir-4656
;
hsa-mir-4673
;
hsa-mir-4681
;
hsa-mir-4722-5p
;
hsa-mir-4731-5p
;
hsa-mir-4736
;
hsa-mir-4747-5p
;
hsa-mir-4770
;
hsa-mir-4804-5p
;
hsa-mir-5001-5p
;
hsa-mir-501-3p
;
hsa-mir-502-3p
;
hsa-mir-5196-5p
;
hsa-mir-520a-5p
;
hsa-mir-525-5p
;
hsa-mir-539-5p
;
hsa-mir-5787
;
hsa-mir-6088
;
hsa-mir-6746-3p
;
hsa-mir-6805-5p
;
hsa-mir-6846-5p
;
hsa-mir-6848-5p
;
hsa-mir-7150
;
hsa-mir-762
Nearest miRNA
hsa-mir-339/Upstream/110855; hsa-mir-10399/Downstream/105068;
Nearest TSS
ENST00000635602/Upstream/3900;
ENST00000416608/Downstream/43243;
Nearest CpG islands
None/Target,
chr7-CpG: 39/Upstream/1261
,
chr7-CpG: 22/Downstream/701
Upstream sequence
CCCACGCCTGGCAGAATCTTCAGTCCTGGCCTAATGAGCTCACCAGCTCAGTAAGTTCTGCGACTGCTTCGGGTTACCAAAAGAATAGAGTATGTAACAG
Downstream sequence
GAGGGAGGCCGTGGCTCCAGTGGGTGCTCCGGAGCTCGTGGGCCCAGCACACCTCCTTAAGCGGGGGATGGAGCGCTGGGAGGGGGTGGACTGTGGCCCA
Reference
Takakuwa, T., et al. Identification of Epstein-Barr virus integrated sites in lymphoblastoid cell line (IB4). Virus Res,2005, 108(1-2): 133-138.
Sample Information
×
Sample name
C666-1
Sample type
Cell line
Gender
Female
CpG Island Information
×
Download
Curate